PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Epidemic Intelligence Service, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.\', \'COVID-19 Response Team, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.\', \'Bloodworks Northwest, Seattle, Washington, USA.\', \'Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.\', \'Washington State Department of Health, Tumwater, Washington, USA.\', \'Division of Clinical Research, National Institute of Allergy and Infectious Diseases, Rockville, Maryland, USA.\', \'Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.\', \'Division of Clinical Research, Integrated Research Facility, NIAID, Rockville, Maryland, USA.\', \'NIAID, Rockville, Maryland, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/trf.16630
?:hasPublicationType
?:journal
  • Transfusion
is ?:pmid of
?:pmid
?:pmid
  • 34510475
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.645
?:rankingScore_hIndex
  • 120
?:title
  • How do I… facilitate a rapid response to a public health emergency requiring plasma collection with a public-private partnership?
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all